JPMORGAN CHASE & CO

Position in NNVC — Nanoviricides, Inc.

CIK 19617 NEW YORK, NY

Position in NNVC

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$4,140

+$1,410 QoQ

Shares Held

3,000

0.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 48 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. NNVC ranks #347 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,140	3,000	0.0%	Shares	Defined	2026-08-12
2026-03-31	$2,730	3,000	0.0%	Shares	Defined	2026-05-13
2025-12-31	$3,390	3,000	+8723.5%	Shares	Defined	2026-02-11
2025-09-30	$48	34	+3.0%	Shares	Defined	2025-11-07
2025-06-30	$46	33	+26.9%	Shares	Defined	2025-08-12
2025-03-31	$30	26	-99.1%	Shares	Defined	2025-05-12
2024-06-30	$5,160	3,000	-0.9%	Shares	Defined	2024-12-26
2024-03-31	$3,511	3,027	+14314.3%	Shares	Defined	2024-12-26
2023-12-31	$21	21	+61.5%	Shares	Defined	2024-12-26
2023-09-30	$17	13	-99.7%	Shares	Defined	2023-11-14
2020-09-30	$14,668	3,820	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.